Global vaccine alliance GAVI has set up financial instruments that will allow the group to immediately access pledged donor funding if it needs to buy vaccines for future pandemics, Chief Executive Seth Berkley told Reuters.
Cetrotide, a drug commonly used by women undergoing in vitro fertilization, will not be available in parts of Europe because of an unidentified production issue with its manufacturer, Merck KGaA.
The new development will arm healthcare providers with a vital tool to naddress the steep rise of malaria cases in children living in Africa.
Geneva, 24 November 2021 – Gavi, the Vaccine Alliance n(Gavi) announced today that Switzerland has become the first country to nrespond to the COVAX call to action to trade places in manufacturers’ nproduction queues, encouraging prioritisation of supply to COVAX and nallowing COVAX participants earlier access to COVID-19 vaccine doses. nUpon Gavi’s initiative, Switzerland and Gavi have respectively agreed nwith Moderna to swap the delivery of these doses based on their nrespective procurement contracts with the manufacturer.
Gavi, The Vaccine Alliance, has said that 75 countries have expressed interest to join the COVAX access facility intended to ensure fast and equitable access to Covid-19 vaccines globally.
Gavi Vaccine Alliance seeks $7. 4bn to immunise 300 million people
Lupin CFO quits, to pursue opportunities outside pharma
Valsartan products not currently recalled - Updated November 27, 2018
Valsartan products not currently recalled - Updated August 8, 2018